<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34173837</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>02</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1420-9071</ISSN><JournalIssue CitedMedium="Internet"><Volume>78</Volume><Issue>15</Issue><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Cellular and molecular life sciences : CMLS</Title><ISOAbbreviation>Cell Mol Life Sci</ISOAbbreviation></Journal><ArticleTitle>DNA damage as a mechanism of neurodegeneration in ALS and a contributor to astrocyte toxicity.</ArticleTitle><Pagination><StartPage>5707</StartPage><EndPage>5729</EndPage><MedlinePgn>5707-5729</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00018-021-03872-0</ELocationID><Abstract><AbstractText>Increasing evidence supports the involvement of DNA damage in several neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS). Elevated levels of DNA damage are consistently observed in both sporadic and familial forms of ALS and may also play a role in Western Pacific ALS, which is thought to have an environmental cause. The cause of DNA damage in ALS remains unclear but likely differs between genetic subgroups. Repeat expansion in the C9ORF72 gene is the most common genetic cause of familial ALS and responsible for about 10% of sporadic cases. These genetic mutations are known to cause R-loops, thus increasing genomic instability and DNA damage, and generate dipeptide repeat proteins, which have been shown to lead to DNA damage and impairment of the DNA damage response. Similarly, several genes associated with ALS including TARDBP, FUS, NEK1, SQSTM1 and SETX are known to play a role in DNA repair and the DNA damage response, and thus may contribute to neuronal death via these pathways. Another consistent feature present in both sporadic and familial ALS is the ability of astrocytes to induce motor neuron death, although the factors causing this toxicity remain largely unknown. In this review, we summarise the evidence for DNA damage playing a causative or secondary role in the pathogenesis of ALS as well as discuss the possible mechanisms involved in different genetic subtypes with particular focus on the role of astrocytes initiating or perpetuating DNA damage in neurons.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kok</LastName><ForeName>Jannigje Rachel</ForeName><Initials>JR</Initials><Identifier Source="ORCID">0000-0001-7185-1329</Identifier><AffiliationInfo><Affiliation>University of Sheffield, Sheffield Institute for Translational Neuroscience (SITraN), Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palminha</LastName><ForeName>Nelma M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology and Biotechnology, The Healthy Lifespan Institute, Sheffield, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Institute of Neuroscience, University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dos Santos Souza</LastName><ForeName>Cleide</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-5314-6263</Identifier><AffiliationInfo><Affiliation>University of Sheffield, Sheffield Institute for Translational Neuroscience (SITraN), Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Khamisy</LastName><ForeName>Sherif F</ForeName><Initials>SF</Initials><Identifier Source="ORCID">0000-0001-6781-3477</Identifier><AffiliationInfo><Affiliation>Department of Molecular Biology and Biotechnology, The Healthy Lifespan Institute, Sheffield, UK. s.el-khamisy@sheffield.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Institute of Neuroscience, University of Sheffield, Sheffield, UK. s.el-khamisy@sheffield.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Institute of Cancer Therapeutics, West Yorkshire, UK. s.el-khamisy@sheffield.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferraiuolo</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-9118-5714</Identifier><AffiliationInfo><Affiliation>University of Sheffield, Sheffield Institute for Translational Neuroscience (SITraN), Sheffield, UK. l.ferraiuolo@sheffield.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Institute of Neuroscience, University of Sheffield, Sheffield, UK. l.ferraiuolo@sheffield.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/W00416X/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>103844</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/R015902/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID># SBF002\1142</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>137661</GrantID><Agency>Lister Institute of Preventive Medicine</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cell Mol Life Sci</MedlineTA><NlmUniqueID>9705402</NlmUniqueID><ISSNLinking>1420-682X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="N">DNA Damage</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Astrocytes</Keyword><Keyword MajorTopicYN="N">DNA damage</Keyword><Keyword MajorTopicYN="N">DNA damage response</Keyword><Keyword MajorTopicYN="N">Neurodegeneration</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>26</Day><Hour>12</Hour><Minute>6</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34173837</ArticleId><ArticleId IdType="pmc">PMC8316199</ArticleId><ArticleId IdType="doi">10.1007/s00018-021-03872-0</ArticleId><ArticleId IdType="pii">10.1007/s00018-021-03872-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Goetz CG. Amyotrophic lateral sclerosis: early contributions of Jean Martin Charcot. Muscle Nerve. 2000;23:336&#x2013;343. doi: 10.1002/(sici)1097-4598(200003)23:3&lt;336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(sici)1097-4598(200003)23:3&lt;336</ArticleId><ArticleId IdType="pubmed">10679709</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarei S, Carr K, Reiley L, et al. A comprehensive review of amyotrophic lateral sclerosis. Surg Neurol Int. 2015 doi: 10.4103/2152-7806.169561.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2152-7806.169561</ArticleId><ArticleId IdType="pmc">PMC4653353</ArticleId><ArticleId IdType="pubmed">26629397</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshino H, Kimura A. Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (Phase II study) Amyotroph Lateral Scler. 2006;7:247&#x2013;251. doi: 10.1080/17482960600881870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960600881870</ArticleId><ArticleId IdType="pubmed">17127563</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller RG, Mitchell JD, Moore DH. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) Cochrane Database Syst Rev. 2012 doi: 10.1002/14651858.CD001447.pub3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD001447.pub3</ArticleId><ArticleId IdType="pmc">PMC7055506</ArticleId><ArticleId IdType="pubmed">22419278</ArticleId></ArticleIdList></Reference><Reference><Citation>Tandan R, Bradley WG. Amyotrophic lateral sclerosis: Part 1. Clinical features, pathology, and ethical issues in management. Ann Neurol. 1985;18:271&#x2013;280. doi: 10.1002/ana.410180302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410180302</ArticleId><ArticleId IdType="pubmed">4051456</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne S, Walsh C, Lynch C, et al. Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2011;82:623&#x2013;627. doi: 10.1136/jnnp.2010.224501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.224501</ArticleId><ArticleId IdType="pubmed">21047878</ArticleId></ArticleIdList></Reference><Reference><Citation>Spencer PS. Guam ALS/Parkinsonism-Dementia: a long-latency neurotoxic disorder caused by &#x201c;slow toxin(s)&#x201d; in food? Can J Neurol Sci. 1987;14:347&#x2013;357. doi: 10.1017/S0317167100037732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0317167100037732</ArticleId><ArticleId IdType="pubmed">3315142</ArticleId></ArticleIdList></Reference><Reference><Citation>Spencer PS, Fry RC, Palmer VS, Kisby GE. Western Pacific ALS-PDC: a prototypical neurodegenerative disorder linked to DNA damage and aberrant proteogenesis? Front Neurol. 2012;3:180. doi: 10.3389/fneur.2012.00180.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2012.00180</ArticleId><ArticleId IdType="pmc">PMC3527830</ArticleId><ArticleId IdType="pubmed">23267344</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/J.NEURON.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.NEURON.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/J.NEURON.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.NEURON.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L, Kirby J, Grierson AJ, et al. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat Rev Neurol. 2011;7:616&#x2013;630. doi: 10.1038/nrneurol.2011.152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.152</ArticleId><ArticleId IdType="pubmed">22051914</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrante RJ, Browne SE, Shinobu LA, et al. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem. 1997;69:2064&#x2013;2074. doi: 10.1046/j.1471-4159.1997.69052064.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1997.69052064.x</ArticleId><ArticleId IdType="pubmed">9349552</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzmaurice PS, Shaw IC, Kleiner HE, et al. Evidence for DNA damage in amyotrophic lateral sclerosis. Muscle Nerve. 1996;19:797&#x2013;798.</Citation><ArticleIdList><ArticleId IdType="pubmed">8609941</ArticleId></ArticleIdList></Reference><Reference><Citation>Valori CF, Brambilla L, Martorana F, Rossi D. The multifaceted role of glial cells in amyotrophic lateral sclerosis. Cell Mol Life Sci. 2014;71:287&#x2013;297. doi: 10.1007/s00018-013-1429-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-013-1429-7</ArticleId><ArticleId IdType="pubmed">23912896</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidet-Phillips AM, Hester ME, Miranda CJ, et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol. 2011;29:824&#x2013;828. doi: 10.1038/nbt.1957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1957</ArticleId><ArticleId IdType="pmc">PMC3170425</ArticleId><ArticleId IdType="pubmed">21832997</ArticleId></ArticleIdList></Reference><Reference><Citation>Westergard T, Jensen BK, Wen X, et al. Cell-to-cell transmission of dipeptide repeat proteins linked to C9orf72-ALS/FTD. Cell Rep. 2016;17:645&#x2013;652. doi: 10.1016/j.celrep.2016.09.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.09.032</ArticleId><ArticleId IdType="pmc">PMC5078984</ArticleId><ArticleId IdType="pubmed">27732842</ArticleId></ArticleIdList></Reference><Reference><Citation>Madill M, McDonagh K, Ma J, et al. Amyotrophic lateral sclerosis patient iPSC-derived astrocytes impair autophagy via non-cell autonomous mechanisms. Mol Brain. 2017 doi: 10.1186/s13041-017-0300-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-017-0300-4</ArticleId><ArticleId IdType="pmc">PMC5470320</ArticleId><ArticleId IdType="pubmed">28610619</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J, Blair IP, Tripathi VB, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski TJ, Bosco DA, LeClerc AL, et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C, Rogelj B, Hortob&#xe1;gyi T, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208&#x2013;1211. doi: 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenna KP, van Doormaal PTC, Dekker AM, et al. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. Nat Genet. 2016;48:1037&#x2013;1042. doi: 10.1038/ng.3626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3626</ArticleId><ArticleId IdType="pmc">PMC5560030</ArticleId><ArticleId IdType="pubmed">27455347</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruyama H, Morino H, Ito H, et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature. 2010;465:223&#x2013;226. doi: 10.1038/nature08971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08971</ArticleId><ArticleId IdType="pubmed">20428114</ArticleId></ArticleIdList></Reference><Reference><Citation>Fecto F, Yan J, Vemula SP, et al. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch Neurol. 2011;68:1440&#x2013;1446. doi: 10.1001/archneurol.2011.250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2011.250</ArticleId><ArticleId IdType="pubmed">22084127</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson JO, Mandrioli J, Benatar M, et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron. 2010;68:857&#x2013;864. doi: 10.1016/j.neuron.2010.11.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.11.036</ArticleId><ArticleId IdType="pmc">PMC3032425</ArticleId><ArticleId IdType="pubmed">21145000</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui R, Tuo M, Li P, Zhou C. Association between TBK1 mutations and risk of amyotrophic lateral sclerosis/frontotemporal dementia spectrum: a meta-analysis. Neurol Sci. 2018;39:811&#x2013;820. doi: 10.1007/s10072-018-3246-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-018-3246-0</ArticleId><ArticleId IdType="pubmed">29349657</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YZ, Bennett CL, Huynh HM, et al. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4) Am J Hum Genet. 2004;74:1128&#x2013;1135. doi: 10.1086/421054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/421054</ArticleId><ArticleId IdType="pmc">PMC1182077</ArticleId><ArticleId IdType="pubmed">15106121</ArticleId></ArticleIdList></Reference><Reference><Citation>Helal M, Mazaheri N, Shalbafan B, et al. Clinical presentation and natural history of infantile-onset ascending spastic paralysis from three families with an ALS2 founder variant. Neurol Sci. 2018;39:1917&#x2013;1925. doi: 10.1007/s10072-018-3526-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-018-3526-8</ArticleId><ArticleId IdType="pubmed">30128655</ArticleId></ArticleIdList></Reference><Reference><Citation>Genin EC, Plutino M, Bannwarth S, et al. CHCHD10 mutations promote loss of mitochondrial cristae junctions with impaired mitochondrial genome maintenance and inhibition of apoptosis. EMBO Mol Med. 2016;8:58&#x2013;72. doi: 10.15252/emmm.201505496.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201505496</ArticleId><ArticleId IdType="pmc">PMC4718158</ArticleId><ArticleId IdType="pubmed">26666268</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkinson N, Ince PG, Smith MO, et al. ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B) Neurology. 2006;67:1074&#x2013;1077. doi: 10.1212/01.wnl.0000231510.89311.8b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000231510.89311.8b</ArticleId><ArticleId IdType="pubmed">16807408</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson JO, Pioro EP, Boehringer A, et al. Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis. Nat Neurosci. 2014;17:664&#x2013;666. doi: 10.1038/nn.3688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3688</ArticleId><ArticleId IdType="pmc">PMC4000579</ArticleId><ArticleId IdType="pubmed">24686783</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu CH, Fallini C, Ticozzi N, et al. Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature. 2012;488:499&#x2013;503. doi: 10.1038/nature11280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11280</ArticleId><ArticleId IdType="pmc">PMC3575525</ArticleId><ArticleId IdType="pubmed">22801503</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng HX, Chen W, Hong ST, et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature. 2011;477:211&#x2013;215. doi: 10.1038/nature10353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10353</ArticleId><ArticleId IdType="pmc">PMC3169705</ArticleId><ArticleId IdType="pubmed">21857683</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura AL, Mitne-Neto M, Silva HCA, et al. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am J Hum Genet. 2004;75:822&#x2013;831. doi: 10.1086/425287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/425287</ArticleId><ArticleId IdType="pmc">PMC1182111</ArticleId><ArticleId IdType="pubmed">15372378</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghasemi M, Brown RH. Genetics of amyotrophic lateral sclerosis. Cold Spring Harb Perspect Med. 2017;8:a024125. doi: 10.1101/cshperspect.a024125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a024125</ArticleId><ArticleId IdType="pmc">PMC5932579</ArticleId><ArticleId IdType="pubmed">28270533</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature. 2009;461:1071&#x2013;1078. doi: 10.1038/nature08467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08467</ArticleId><ArticleId IdType="pmc">PMC2906700</ArticleId><ArticleId IdType="pubmed">19847258</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazak L, Reyes A, Holt IJ. Minimizing the damage: repair pathways keep mitochondrial DNA intact. Nat Rev Mol Cell Biol. 2012;13:659&#x2013;671. doi: 10.1038/nrm3439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3439</ArticleId><ArticleId IdType="pubmed">22992591</ArticleId></ArticleIdList></Reference><Reference><Citation>Giglia-Mari G, Zotter A, Vermeulen W. DNA damage response. Cold Spring Harb Perspect Biol. 2011;3:a000745. doi: 10.1101/cshperspect.a000745.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a000745</ArticleId><ArticleId IdType="pmc">PMC3003462</ArticleId><ArticleId IdType="pubmed">20980439</ArticleId></ArticleIdList></Reference><Reference><Citation>Valavanidis A, Vlachogianni T, Fiotakis C. 8-hydroxy-2&#x2032; -deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Heal Part C. 2009;27:120&#x2013;139. doi: 10.1080/10590500902885684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10590500902885684</ArticleId><ArticleId IdType="pubmed">19412858</ArticleId></ArticleIdList></Reference><Reference><Citation>Burma S, Chen DJ. Role of DNA-PK in the cellular response to DNA double-strand breaks. DNA Repair (Amst) 2004;3:909&#x2013;918. doi: 10.1016/j.dnarep.2004.03.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dnarep.2004.03.021</ArticleId><ArticleId IdType="pubmed">15279776</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowsheen S, Yang ES. The intersection between DNA damage response and cell death pathways. Exp Oncol. 2012;34:243&#x2013;254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3754840</ArticleId><ArticleId IdType="pubmed">23070009</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeppesen DK, Bohr VA, Stevnsner T. DNA repair deficiency in neurodegeneration. Prog Neurobiol. 2011;94:166&#x2013;200. doi: 10.1016/j.pneurobio.2011.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2011.04.013</ArticleId><ArticleId IdType="pmc">PMC3123739</ArticleId><ArticleId IdType="pubmed">21550379</ArticleId></ArticleIdList></Reference><Reference><Citation>De Waard MC, Van Der Pluijm I, Zuiderveen Borgesius N, et al. Age-related motor neuron degeneration in DNA repair-deficient Ercc1 mice. Acta Neuropathol. 2010;120:461&#x2013;475. doi: 10.1007/s00401-010-0715-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-010-0715-9</ArticleId><ArticleId IdType="pmc">PMC2923326</ArticleId><ArticleId IdType="pubmed">20602234</ArticleId></ArticleIdList></Reference><Reference><Citation>Katyal S, El-Khamisy SF, Russell HR, et al. TDP1 facilitates chromosomal single-strand break repair in neurons and is neuroprotective in vivo. EMBO J. 2007;26:4720&#x2013;4731. doi: 10.1038/sj.emboj.7601869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.emboj.7601869</ArticleId><ArticleId IdType="pmc">PMC2080805</ArticleId><ArticleId IdType="pubmed">17914460</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullaart E, Boerrigter METI, Brouwer A, et al. Age-dependent accumulation of alkali-labile sites in DNA of post-mitotic but not in that of mitotic rat liver cells. Mech Ageing Dev. 1988;45:41&#x2013;49. doi: 10.1016/0047-6374(88)90017-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0047-6374(88)90017-6</ArticleId><ArticleId IdType="pubmed">3216727</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyama T, Wilson DM. DNA repair mechanisms in dividing and non-dividing cells. DNA Repair (Amst) 2013;12:620&#x2013;636. doi: 10.1016/J.DNAREP.2013.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.DNAREP.2013.04.015</ArticleId><ArticleId IdType="pmc">PMC3720834</ArticleId><ArticleId IdType="pubmed">23684800</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykora P, Yang JL, Ferrarelli LK, et al. Modulation of DNA base excision repair during neuronal differentiation. Neurobiol Aging. 2013;34:1717&#x2013;1727. doi: 10.1016/j.neurobiolaging.2012.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.12.016</ArticleId><ArticleId IdType="pmc">PMC5576894</ArticleId><ArticleId IdType="pubmed">23375654</ArticleId></ArticleIdList></Reference><Reference><Citation>Nouspikel T, Hanawalt PC. Terminally differentiated human neurons repair transcribed genes but display attenuated global DNA repair and modulation of repair gene expression. Mol Cell Biol. 2000;20:1562&#x2013;1570. doi: 10.1128/mcb.20.5.1562-1570.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mcb.20.5.1562-1570.2000</ArticleId><ArticleId IdType="pmc">PMC85340</ArticleId><ArticleId IdType="pubmed">10669734</ArticleId></ArticleIdList></Reference><Reference><Citation>Madabhushi R, Gao F, Pfenning AR, et al. Activity-induced DNA breaks govern the expression of neuronal early-response genes. Cell. 2015;161:1592&#x2013;1605. doi: 10.1016/j.cell.2015.05.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.05.032</ArticleId><ArticleId IdType="pmc">PMC4886855</ArticleId><ArticleId IdType="pubmed">26052046</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaksauskaite R, Thomas RC, van Eeden F, El-Khamisy SF. Tdp1 protects from topoisomerase 1&#x2013;mediated chromosomal breaks in adult zebrafish but is dispensable during larval development. Sci Adv. 2021;7:4165. doi: 10.1126/sciadv.abc4165d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abc4165d</ArticleId><ArticleId IdType="pmc">PMC7846158</ArticleId><ArticleId IdType="pubmed">33514542</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin LJ, Wong M. Enforced DNA repair enzymes rescue neurons from apoptosis induced by target deprivation and axotomy in mouse models of neurodegeneration. Mech Ageing Dev. 2017;161:149&#x2013;162. doi: 10.1016/j.mad.2016.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mad.2016.06.011</ArticleId><ArticleId IdType="pmc">PMC5192008</ArticleId><ArticleId IdType="pubmed">27364693</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasko MR, Guo C, Kelley MR. The multifunctional DNA repair/redox enzyme Ape1/Ref-1 promotes survival of neurons after oxidative stress. DNA Repair (Amst) 2005;4:367&#x2013;379. doi: 10.1016/j.dnarep.2004.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dnarep.2004.11.006</ArticleId><ArticleId IdType="pubmed">15661660</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruman II, Wersto RP, Cardozo-Pelaez F, et al. Cell cycle activation linked to neuronal cell death initiated by DNA damage. Neuron. 2004;41:549&#x2013;561. doi: 10.1016/S0896-6273(04)00017-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(04)00017-0</ArticleId><ArticleId IdType="pubmed">14980204</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardinale A, Paldino E, Giamp&#xe0; C, et al. PARP-1 inhibition is neuroprotective in the R6/2 mouse model of huntington&#x2019;s disease. PLoS ONE. 2015 doi: 10.1371/journal.pone.0134482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0134482</ArticleId><ArticleId IdType="pmc">PMC4529170</ArticleId><ArticleId IdType="pubmed">26252217</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelkarim GE, Gertz K, Harms C, et al. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke. Int J Mol Med. 2001;7:255&#x2013;260. doi: 10.3892/ijmm.7.3.255.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.7.3.255</ArticleId><ArticleId IdType="pubmed">11179503</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez R, Lu Y, Gendron TF, et al. Poly(GR) in C9ORF72-related ALS/FTD compromises mitochondrial function and increases oxidative stress and DNA damage in iPSC-derived motor neurons. Neuron. 2016;92:383&#x2013;391. doi: 10.1016/J.NEURON.2016.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.NEURON.2016.09.015</ArticleId><ArticleId IdType="pmc">PMC5111366</ArticleId><ArticleId IdType="pubmed">27720481</ArticleId></ArticleIdList></Reference><Reference><Citation>Higelin J, Catanese A, Semelink-Sedlacek LL, et al. NEK1 loss-of-function mutation induces DNA damage accumulation in ALS patient-derived motoneurons. Stem Cell Res. 2018;30:150&#x2013;162. doi: 10.1016/J.SCR.2018.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.SCR.2018.06.005</ArticleId><ArticleId IdType="pubmed">29929116</ArticleId></ArticleIdList></Reference><Reference><Citation>Farg MA, Konopka A, Soo KY, et al. The DNA damage response (DDR) is induced by the C9orf72 repeat expansion in amyotrophic lateral sclerosis. Hum Mol Genet. 2017;26:2882&#x2013;2896. doi: 10.1093/hmg/ddx170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx170</ArticleId><ArticleId IdType="pubmed">28481984</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker C, Herranz-Martin S, Karyka E, et al. C9orf72 expansion disrupts ATM-mediated chromosomal break repair. Nat Neurosci. 2017;20:1225&#x2013;1235. doi: 10.1038/nn.4604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4604</ArticleId><ArticleId IdType="pmc">PMC5578434</ArticleId><ArticleId IdType="pubmed">28714954</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade NS, Ramic M, Esanov R, et al. Dipeptide repeat proteins inhibit homology-directed DNA double strand break repair in C9ORF72 ALS/FTD. Mol Neurodegener. 2020;15:1&#x2013;18. doi: 10.1186/s13024-020-00365-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00365-9</ArticleId><ArticleId IdType="pmc">PMC7041170</ArticleId><ArticleId IdType="pubmed">32093728</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R, Isaacs AM. C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat Rev Neurol. 2018;14:544&#x2013;558. doi: 10.1038/s41582-018-0047-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0047-2</ArticleId><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Nihei Y, Mori K, Werner G, et al. Poly-glycine&#x2013;alanine exacerbates C9orf72 repeat expansion-mediated DNA damage via sequestration of phosphorylated ATM and loss of nuclear hnRNPA3. Acta Neuropathol. 2020;139:99&#x2013;118. doi: 10.1007/s00401-019-02082-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02082-0</ArticleId><ArticleId IdType="pmc">PMC6942035</ArticleId><ArticleId IdType="pubmed">31642962</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SY, Lopez-Gonzalez R, Krishnan G, et al. C9ORF72-ALS/FTD-associated poly(GR) binds Atp5a1 and compromises mitochondrial function in vivo. Nat Neurosci. 2019;22:851&#x2013;862. doi: 10.1038/s41593-019-0397-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0397-0</ArticleId><ArticleId IdType="pmc">PMC6800116</ArticleId><ArticleId IdType="pubmed">31086314</ArticleId></ArticleIdList></Reference><Reference><Citation>May S, Hornburg D, Schludi MH, et al. C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration. Acta Neuropathol. 2014;128:485&#x2013;503. doi: 10.1007/s00401-014-1329-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1329-4</ArticleId><ArticleId IdType="pmc">PMC4159571</ArticleId><ArticleId IdType="pubmed">25120191</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen X, Tan W, Westergard T, et al. Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death. Neuron. 2014;84:1213&#x2013;1225. doi: 10.1016/J.NEURON.2014.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.NEURON.2014.12.010</ArticleId><ArticleId IdType="pmc">PMC4632245</ArticleId><ArticleId IdType="pubmed">25521377</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang D, Abdallah A, Li Z, et al. FTD/ALS-associated poly(GR) protein impairs the Notch pathway and is recruited by poly(GA) into cytoplasmic inclusions. Acta Neuropathol. 2015;130:525&#x2013;535. doi: 10.1007/s00401-015-1448-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1448-6</ArticleId><ArticleId IdType="pmc">PMC4575383</ArticleId><ArticleId IdType="pubmed">26031661</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker C, El-Khamisy SF. Perturbed autophagy and DNA repair converge to promote neurodegeneration in amyotrophic lateral sclerosis and dementia. Brain. 2018;141:1247&#x2013;1262. doi: 10.1093/brain/awy076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy076</ArticleId><ArticleId IdType="pmc">PMC5917746</ArticleId><ArticleId IdType="pubmed">29584802</ArticleId></ArticleIdList></Reference><Reference><Citation>Cristini A, Ricci G, Capranico G, et al. Dual processing of R-loops and topoisomerase I induces transcription-dependent DNA double-strand breaks. Cell Rep. 2019;28:3167&#x2013;3181. doi: 10.1016/j.celrep.2019.08.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.08.041</ArticleId><ArticleId IdType="pmc">PMC8274950</ArticleId><ArticleId IdType="pubmed">31533039</ArticleId></ArticleIdList></Reference><Reference><Citation>Teng Y, Yadav T, Duan M, et al. ROS-induced R loops trigger a transcription-coupled but BRCA1/2-independent homologous recombination pathway through CSB. Nat Commun. 2018;9:1&#x2013;12. doi: 10.1038/s41467-018-06586-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-06586-3</ArticleId><ArticleId IdType="pmc">PMC6175878</ArticleId><ArticleId IdType="pubmed">30297739</ArticleId></ArticleIdList></Reference><Reference><Citation>Sordet O, Redon CE, Guirouilh-Barbat J, et al. Ataxia telangiectasia mutated activation by transcription- and topoisomerase I-induced DNA double-strand breaks. EMBO Rep. 2009;10:887&#x2013;893. doi: 10.1038/embor.2009.97.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/embor.2009.97</ArticleId><ArticleId IdType="pmc">PMC2726680</ArticleId><ArticleId IdType="pubmed">19557000</ArticleId></ArticleIdList></Reference><Reference><Citation>Alagoz M, Chiang S, Sharma A, El-khamisy SF. ATM deficiency results in accumulation of DNA-topoisomerase I covalent intermediates in neural cells. PLoS ONE. 2013;8:e58239. doi: 10.1371/journal.pone.0058239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0058239</ArticleId><ArticleId IdType="pmc">PMC3634035</ArticleId><ArticleId IdType="pubmed">23626666</ArticleId></ArticleIdList></Reference><Reference><Citation>Usdin K, House NCM, Freudenreich CH. Repeat instability during DNA repair: Insights from model systems. Crit Rev Biochem Mol Biol. 2015;50:142&#x2013;167. doi: 10.3109/10409238.2014.999192.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/10409238.2014.999192</ArticleId><ArticleId IdType="pmc">PMC4454471</ArticleId><ArticleId IdType="pubmed">25608779</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez R, Yang D, Pribadi M, et al. Partial inhibition of the overactivated Ku80-dependent DNA repair pathway rescues neurodegeneration in C9ORF72-ALS/FTD. Proc Natl Acad Sci USA. 2019;116:9628&#x2013;9633. doi: 10.1073/pnas.1901313116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1901313116</ArticleId><ArticleId IdType="pmc">PMC6511021</ArticleId><ArticleId IdType="pubmed">31019093</ArticleId></ArticleIdList></Reference><Reference><Citation>Maor-Nof M, Shipony Z, Lopez-Gonzalez R, et al. p53 is a central regulator driving neurodegeneration caused by C9orf72 poly(PR) Cell. 2021;184:689&#x2013;708. doi: 10.1016/j.cell.2020.12.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.12.025</ArticleId><ArticleId IdType="pmc">PMC7886018</ArticleId><ArticleId IdType="pubmed">33482083</ArticleId></ArticleIdList></Reference><Reference><Citation>Riemslagh FW, Lans H, Seelaar H, et al. HR23B pathology preferentially co-localizes with p62, pTDP-43 and poly-GA in C9ORF72-linked frontotemporal dementia and amyotrophic lateral sclerosis. Acta Neuropathol Commun. 2019;7:39. doi: 10.1186/s40478-019-0694-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0694-6</ArticleId><ArticleId IdType="pmc">PMC6416930</ArticleId><ArticleId IdType="pubmed">30867060</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin MH, Oh DY. ATM in DNA repair in cancer. Pharmacol Ther. 2019;203:107391. doi: 10.1016/j.pharmthera.2019.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2019.07.002</ArticleId><ArticleId IdType="pubmed">31299316</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis AJ, Chen DJ. DNA double strand break repair via non-homologous end-joining. Transl Cancer Res. 2013;2:130&#x2013;143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3758668</ArticleId><ArticleId IdType="pubmed">24000320</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasten U, Borgmann K, Burgmann P, et al. Overexpression of human Ku70/Ku80 in rat cells resulting in reduced DSB repair capacity with appropriate increase in cell radiosensitivity but with no effect on cell recovery. Radiat Res. 1999;151:532&#x2013;539. doi: 10.2307/3580029.</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/3580029</ArticleId><ArticleId IdType="pubmed">10319726</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Z-Y, Zhou Z-R, Che C-H, et al. Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2017;88:540&#x2013;549. doi: 10.1136/jnnp-2016-315018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-315018</ArticleId><ArticleId IdType="pubmed">28057713</ArticleId></ArticleIdList></Reference><Reference><Citation>Saccon RA, Bunton-Stasyshyn RKA, Fisher EMC, Fratta P. Is SOD1 loss of function involved in amyotrophic lateral sclerosis? Brain. 2013;136:2342&#x2013;2358. doi: 10.1093/brain/awt097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awt097</ArticleId><ArticleId IdType="pmc">PMC3722346</ArticleId><ArticleId IdType="pubmed">23687121</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogdanov M, Brown RH, Matson W, et al. Increased oxidative damage to DNA in ALS patients. Free Radic Biol Med. 2000;29:652&#x2013;658. doi: 10.1016/S0891-5849(00)00349-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0891-5849(00)00349-X</ArticleId><ArticleId IdType="pubmed">11033417</ArticleId></ArticleIdList></Reference><Reference><Citation>Ihara Y, Nobukuni K, Takata H, Hayabara T. Oxidative stress and metal content in blood and cerebrospinal fluid of amyotrophic lateral sclerosis patients with and without a Cu, Zn-superoxide dismutase mutation. Neurol Res. 2005;27:105&#x2013;108. doi: 10.1179/016164105X18430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/016164105X18430</ArticleId><ArticleId IdType="pubmed">15829169</ArticleId></ArticleIdList></Reference><Reference><Citation>Penndorf D, Tadi&#x107; V, Witte OW, et al. DNA strand breaks and TDP-43 mislocation are absent in the murine hSOD1G93A model of amyotrophic lateral sclerosis in vivo and in vitro. PLoS ONE. 2017;12:e0183684. doi: 10.1371/JOURNAL.PONE.0183684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PONE.0183684</ArticleId><ArticleId IdType="pmc">PMC5568271</ArticleId><ArticleId IdType="pubmed">28832631</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang L, Teuchert M, Huber-Abel F, et al. MMP-2 and MMP-9 are elevated in spinal cord and skin in a mouse model of ALS. J Neurol Sci. 2010;294:51&#x2013;56. doi: 10.1016/J.JNS.2010.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JNS.2010.04.005</ArticleId><ArticleId IdType="pubmed">20441996</ArticleId></ArticleIdList></Reference><Reference><Citation>Warita H, Hayashi T, Murakami T, et al. Oxidative damage to mitochondrial DNA in spinal motoneurons of transgenic ALS mice. Mol Brain Res. 2001;89:147&#x2013;152. doi: 10.1016/S0169-328X(01)00029-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0169-328X(01)00029-8</ArticleId><ArticleId IdType="pubmed">11311985</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguirre N, Flint Beal M, Matson WR, Bogdanov MB. Increased oxidative damage to DNA in an animal model of amyotrophic lateral sclerosis. Free Radic Res. 2005;39:383&#x2013;388. doi: 10.1080/10715760400027979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10715760400027979</ArticleId><ArticleId IdType="pubmed">16028363</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Song Moh MS, et al. Cytoplasmic restriction of mutated SOD1 impairs the DNA repair process in spinal cord neurons. Cells. 2019;8:1502. doi: 10.3390/cells8121502.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8121502</ArticleId><ArticleId IdType="pmc">PMC6952796</ArticleId><ArticleId IdType="pubmed">31771229</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres P, Cacabelos D, Pairada J, et al. Gender-specific beneficial effects of docosahexaenoic acid dietary supplementation in G93A-SOD1 amyotrophic lateral sclerosis mice. Neurotherapeutics. 2020;17:269&#x2013;281. doi: 10.1007/s13311-019-00808-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-019-00808-2</ArticleId><ArticleId IdType="pmc">PMC7007454</ArticleId><ArticleId IdType="pubmed">31755041</ArticleId></ArticleIdList></Reference><Reference><Citation>Brasil AA, Magalh&#xe3;es RSS, De Carvalho MDC, et al. Implications of fALS mutations on Sod1 function and oligomerization in cell models. Mol Neurobiol. 2018;55:5269&#x2013;5281. doi: 10.1007/s12035-017-0755-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0755-4</ArticleId><ArticleId IdType="pmc">PMC5948255</ArticleId><ArticleId IdType="pubmed">28884318</ArticleId></ArticleIdList></Reference><Reference><Citation>Sau D, De Biasi S, Vitellaro-Zuccarello L, et al. Mutation of SOD1 in ALS: a gain of a loss of function. Hum Mol Genet. 2007;16:1604&#x2013;1618. doi: 10.1093/hmg/ddm110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddm110</ArticleId><ArticleId IdType="pubmed">17504823</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbosa LF, Cerqueira FM, Macedo AFA, et al. Increased SOD1 association with chromatin, DNA damage, p53 activation, and apoptosis in a cellular model of SOD1-linked ALS. Biochim Biophys Acta Mol Basis Dis. 2010;1802:462&#x2013;471. doi: 10.1016/J.BBADIS.2010.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.BBADIS.2010.01.011</ArticleId><ArticleId IdType="pubmed">20097285</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X-D, Zhu M-W, Shan D, et al. Spy1, a unique cell cycle regulator, alters viability in ALS motor neurons and cell lines in response to mutant SOD1-induced DNA damage. DNA Repair (Amst) 2019;74:51&#x2013;62. doi: 10.1016/J.DNAREP.2018.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.DNAREP.2018.12.005</ArticleId><ArticleId IdType="pubmed">30630676</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Yang Y, Liang W, et al. Neuroprotection by urate on the mutant hSOD1-related cellular and Drosophila models of amyotrophic lateral sclerosis: Implication for GSH synthesis via activating Akt/GSK3&#x3b2;/Nrf2/GCLC pathways. Brain Res Bull. 2019;146:287&#x2013;301. doi: 10.1016/j.brainresbull.2019.01.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2019.01.019</ArticleId><ArticleId IdType="pubmed">30690059</ArticleId></ArticleIdList></Reference><Reference><Citation>Borchelt DR, Lee MK, Slunt HS, et al. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc Natl Acad Sci USA. 1994;91:8292&#x2013;8296. doi: 10.1073/PNAS.91.17.8292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/PNAS.91.17.8292</ArticleId><ArticleId IdType="pmc">PMC44592</ArticleId><ArticleId IdType="pubmed">8058797</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayward LJ, Rodriguez JA, Kim JW, et al. Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial amyotrophic lateral sclerosis. J Biol Chem. 2002;277:15923&#x2013;15931. doi: 10.1074/jbc.M112087200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112087200</ArticleId><ArticleId IdType="pubmed">11854284</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu R, Narla RK, Kurinov I, et al. Increased hydroxyl radical production and apoptosis in PC12 neuron cells expressing the gain-of-function mutant G93A SOD1 gene. Radiat Res. 1999;151:133&#x2013;141. doi: 10.2307/3579763.</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/3579763</ArticleId><ArticleId IdType="pubmed">9952297</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang YQ, Zheng YH, Zhang CT, et al. Wild-type p53-induced phosphatase 1 down-regulation promotes apoptosis by activating the DNA damage-response pathway in amyotrophic lateral sclerosis. Neurobiol Dis. 2020;134:104648. doi: 10.1016/j.nbd.2019.104648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104648</ArticleId><ArticleId IdType="pubmed">31676238</ArticleId></ArticleIdList></Reference><Reference><Citation>Gertz B, Wong M, Martin LJ. Nuclear localization of human SOD1 and mutant SOD1-specific disruption of survival motor neuron protein complex in transgenic amyotrophic lateral sclerosis mice. J Neuropathol Exp Neurol. 2012;71:162&#x2013;177. doi: 10.1097/NEN.0b013e318244b635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e318244b635</ArticleId><ArticleId IdType="pmc">PMC3432922</ArticleId><ArticleId IdType="pubmed">22249462</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez De Aguilar JL, Gordon JW, Ren&#xe9; F, et al. Alteration of the Bcl-x/Bax ratio in a transgenic mouse model of amyotrophic lateral sclerosis: Evidence for the implication of the p53 signaling pathway. Neurobiol Dis. 2000;7:406&#x2013;415. doi: 10.1006/nbdi.2000.0295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.2000.0295</ArticleId><ArticleId IdType="pubmed">10964611</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaikh AY, Martin LJ. DNA base-excision repair enzyme apurinic/apyrimidinic endonuclease/redox factor-1 is increased and competent in the brain and spinal cord of individuals with amyotrophic lateral sclerosis. NeuroMolecular Med. 2002;2:47&#x2013;60. doi: 10.1007/s12017-002-0038-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12017-002-0038-7</ArticleId><ArticleId IdType="pubmed">12230304</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagano I, Murakami T, Manabe Y, Abe K (2002) Early decrease of survival factors and DNA repair enzyme in spinal motor neurons of presymptomatic transgenic mice that express a mutant SOD1 gene. In: Life sciences. Pergamon, pp 541&#x2013;548</Citation><ArticleIdList><ArticleId IdType="pubmed">12467894</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll J, Page TKW, Chiang SC, et al. Expression of a pathogenic mutation of SOD1 sensitizes aprataxin-deficient cells and mice to oxidative stress and triggers hallmarks of premature ageing. Hum Mol Genet. 2015;24:828&#x2013;840. doi: 10.1093/hmg/ddu500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu500</ArticleId><ArticleId IdType="pmc">PMC4291253</ArticleId><ArticleId IdType="pubmed">25274775</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim BW, Jeong YE, Wong M, Martin LJ. DNA damage accumulates and responses are engaged in human ALS brain and spinal motor neurons and DNA repair is activatable in iPSC-derived motor neurons with SOD1 mutations. Acta Neuropathol Commun. 2020;8:1&#x2013;26. doi: 10.1186/s40478-019-0874-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0874-4</ArticleId><ArticleId IdType="pmc">PMC6995159</ArticleId><ArticleId IdType="pubmed">32005289</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A, Buratti E. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins. J Neurochem. 2016;138:95&#x2013;111. doi: 10.1111/jnc.13625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13625</ArticleId><ArticleId IdType="pubmed">27015757</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W-Y, Pan L, Su SC, et al. Interaction of FUS and HDAC1 regulates DNA damage response and repair in neurons. Nat Neurosci. 2013;16:1383&#x2013;1391. doi: 10.1038/nn.3514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3514</ArticleId><ArticleId IdType="pmc">PMC5564396</ArticleId><ArticleId IdType="pubmed">24036913</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumann M, Pal A, Goswami A, et al. Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation. Nat Commun. 2018;9:335. doi: 10.1038/s41467-017-02299-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02299-1</ArticleId><ArticleId IdType="pmc">PMC5780468</ArticleId><ArticleId IdType="pubmed">29362359</ArticleId></ArticleIdList></Reference><Reference><Citation>Higelin J, Demestre M, Putz S, et al. FUS mislocalization and vulnerability to DNA damage in ALS patients derived hiPSCs and aging motoneurons. Front Cell Neurosci. 2016;10:290. doi: 10.3389/fncel.2016.00290.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2016.00290</ArticleId><ArticleId IdType="pmc">PMC5183648</ArticleId><ArticleId IdType="pubmed">28082870</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu H, Lee S, Shang Y, et al. ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects. J Clin Invest. 2014;124:981&#x2013;999. doi: 10.1172/JCI72723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI72723</ArticleId><ArticleId IdType="pmc">PMC3938263</ArticleId><ArticleId IdType="pubmed">24509083</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastrocola AS, Kim SH, Trinh AT, et al. The RNA-binding protein fused in sarcoma (FUS) functions downstream of poly(ADP-ribose) polymerase (PARP) in response to DNA damage. J Biol Chem. 2013;288:24731&#x2013;24741. doi: 10.1074/jbc.M113.497974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.497974</ArticleId><ArticleId IdType="pmc">PMC3750169</ArticleId><ArticleId IdType="pubmed">23833192</ArticleId></ArticleIdList></Reference><Reference><Citation>Rulten SL, Rotheray A, Green RL, et al. PARP-1 dependent recruitment of the amyotrophic lateral sclerosis-associated protein FUS/TLS to sites of oxidative DNA damage. Nucleic Acids Res. 2014;42:307&#x2013;314. doi: 10.1093/nar/gkt835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkt835</ArticleId><ArticleId IdType="pmc">PMC3874156</ArticleId><ArticleId IdType="pubmed">24049082</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill SJ, Mordes DA, Cameron LA, et al. Two familial ALS proteins function in prevention/repair of transcription-associated DNA damage. Proc Natl Acad Sci USA. 2016;113:E7701&#x2013;E7709. doi: 10.1073/pnas.1611673113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1611673113</ArticleId><ArticleId IdType="pmc">PMC5137757</ArticleId><ArticleId IdType="pubmed">27849576</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuta R, Larochelle N, Fernandez M, et al. Depending on the stress, histone deacetylase inhibitors act as heat shock protein co-inducers in motor neurons and potentiate arimoclomol, exerting neuroprotection through multiple mechanisms in ALS models. Cell Stress Chaperones. 2020;25:173&#x2013;191. doi: 10.1007/s12192-019-01064-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-019-01064-1</ArticleId><ArticleId IdType="pmc">PMC6985055</ArticleId><ArticleId IdType="pubmed">31900865</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Rangaswamy S, Kodavati M, et al. RT2 PCR array screening reveals distinct perturbations in DNA damage response signaling in FUS-associated motor neuron disease. Mol Brain. 2019 doi: 10.1186/s13041-019-0526-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-019-0526-4</ArticleId><ArticleId IdType="pmc">PMC6894127</ArticleId><ArticleId IdType="pubmed">31801573</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, Hasegawa M, Akiyama H, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351:602&#x2013;611. doi: 10.1016/J.BBRC.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.BBRC.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreiter N, Pal A, Lojewski X, et al. Age-dependent neurodegeneration and organelle transport deficiencies in mutant TDP43 patient-derived neurons are independent of TDP43 aggregation. Neurobiol Dis. 2018;115:167&#x2013;181. doi: 10.1016/J.NBD.2018.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.NBD.2018.03.010</ArticleId><ArticleId IdType="pubmed">29630989</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero EN, Mitra J, Wang H, et al. Amyotrophic lateral sclerosis-associated TDP-43 mutation Q331K prevents nuclear translocation of XRCC4-DNA ligase 4 complex and is linked to genome damage-mediated neuronal apoptosis. Hum Mol Genet. 2019;28:2459&#x2013;2476. doi: 10.1093/hmg/ddz062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddz062</ArticleId><ArticleId IdType="pmc">PMC6659010</ArticleId><ArticleId IdType="pubmed">31067307</ArticleId></ArticleIdList></Reference><Reference><Citation>Konopka A, Whelan DR, Jamali MS, et al. Impaired NHEJ repair in amyotrophic lateral sclerosis is associated with TDP-43 mutations. Mol Neurodegener. 2020;15:51. doi: 10.1186/s13024-020-00386-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00386-4</ArticleId><ArticleId IdType="pmc">PMC7488163</ArticleId><ArticleId IdType="pubmed">32907630</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitra J, Guerrero EN, Hegde PM, et al. Motor neuron disease-associated loss of nuclear TDP-43 is linked to DNA double-strand break repair defects. Proc Natl Acad Sci USA. 2019;116:4696&#x2013;4705. doi: 10.1073/pnas.1818415116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1818415116</ArticleId><ArticleId IdType="pmc">PMC6410842</ArticleId><ArticleId IdType="pubmed">30770445</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, Chitta RK, High AA, Taylor JP. Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. J Proteome Res. 2010;9:1104&#x2013;1120. doi: 10.1021/pr901076y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr901076y</ArticleId><ArticleId IdType="pmc">PMC2897173</ArticleId><ArticleId IdType="pubmed">20020773</ArticleId></ArticleIdList></Reference><Reference><Citation>Polci R, Peng A, Chen P-L, et al. NIMA-related protein kinase 1 is involved early in the ionizing radiation-induced DNA damage response. Cancer Res. 2004;64:8800&#x2013;8803. doi: 10.1158/0008-5472.CAN-04-2243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-04-2243</ArticleId><ArticleId IdType="pubmed">15604234</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Chen C-F, Riley DJ, Chen P-L. Nek1 kinase functions in DNA damage response and checkpoint control through a pathway independent of ATM and ATR. Cell Cycle. 2011;10:655&#x2013;663. doi: 10.4161/cc.10.4.14814.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cc.10.4.14814</ArticleId><ArticleId IdType="pmc">PMC3173995</ArticleId><ArticleId IdType="pubmed">21301226</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelegrini AL, Moura DJ, Brenner BL, et al. Nek1 silencing slows down DNA repair and blocks DNA damage-induced cell cycle arrest. Mutagenesis. 2010;25:447&#x2013;454. doi: 10.1093/mutage/geq026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/mutage/geq026</ArticleId><ArticleId IdType="pubmed">20501547</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Chen P-L, Chen C-F, et al. Never-in-mitosis related Kinase 1 functions in DNA damage response and checkpoint control. Cell Cycle. 2008;7:3194&#x2013;3201. doi: 10.4161/cc.7.20.6815.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cc.7.20.6815</ArticleId><ArticleId IdType="pmc">PMC2597191</ArticleId><ArticleId IdType="pubmed">18843199</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz EI, Smilenov LB, Price MA, et al. Cell cycle activation in postmitotic neurons is essential for DNA repair. Cell Cycle. 2007;6:318&#x2013;329. doi: 10.4161/cc.6.3.3752.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cc.6.3.3752</ArticleId><ArticleId IdType="pubmed">17297309</ArticleId></ArticleIdList></Reference><Reference><Citation>Spies J, Waizenegger A, Barton O, et al. Nek1 regulates Rad54 to orchestrate homologous recombination and replication fork stability. Mol Cell. 2016;62:903&#x2013;917. doi: 10.1016/J.MOLCEL.2016.04.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.MOLCEL.2016.04.032</ArticleId><ArticleId IdType="pmc">PMC5503685</ArticleId><ArticleId IdType="pubmed">27264870</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso A, Logroscino G, Jick SS, Hern&#xe1;n MA. Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study. Eur J Neurol. 2009;16:745&#x2013;751. doi: 10.1111/j.1468-1331.2009.02586.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2009.02586.x</ArticleId><ArticleId IdType="pmc">PMC3093130</ArticleId><ArticleId IdType="pubmed">19475756</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorbunova V, Seluanov A, Mao Z, Hine C. Changes in DNA repair during aging. Nucleic Acids Res. 2007;35:7466&#x2013;7474. doi: 10.1093/nar/gkm756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkm756</ArticleId><ArticleId IdType="pmc">PMC2190694</ArticleId><ArticleId IdType="pubmed">17913742</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingre C, Roos PM, Piehl F, et al. Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol. 2015;7:181&#x2013;193. doi: 10.2147/CLEP.S37505.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S37505</ArticleId><ArticleId IdType="pmc">PMC4334292</ArticleId><ArticleId IdType="pubmed">25709501</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SH, Henkel JS, Beers DR, et al. PARP expression is increased in astrocytes but decreased in motor neurons in the spinal cord of sporadic ALS patients. J Neuropathol Exp Neurol. 2003;62:88&#x2013;103. doi: 10.1093/jnen/62.1.88.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/62.1.88</ArticleId><ArticleId IdType="pubmed">12528821</ArticleId></ArticleIdList></Reference><Reference><Citation>Kisby GE, Milne J, Sweatt C. Evidence of reduced DNA repair in amyotrophic lateral sclerosis brain tissue. NeuroReport. 1997;8:1337&#x2013;1340. doi: 10.1097/00001756-199704140-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-199704140-00004</ArticleId><ArticleId IdType="pubmed">9172131</ArticleId></ArticleIdList></Reference><Reference><Citation>De Benedetti S, Lucchini G, Del B&#xf2; C, et al. Blood trace metals in a sporadic amyotrophic lateral sclerosis geographical cluster. Biometals. 2017;30:355&#x2013;365. doi: 10.1007/s10534-017-0011-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10534-017-0011-4</ArticleId><ArticleId IdType="pubmed">28337565</ArticleId></ArticleIdList></Reference><Reference><Citation>Wald-Altman S, Pichinuk E, Kakhlon O, Weil M. A differential autophagy-dependent response to DNA double-strand breaks in bone marrow mesenchymal stem cells from sporadic ALS patients. Dis Model Mech. 2017;10:645&#x2013;654. doi: 10.1242/dmm.027938.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.027938</ArticleId><ArticleId IdType="pmc">PMC5451167</ArticleId><ArticleId IdType="pubmed">28213588</ArticleId></ArticleIdList></Reference><Reference><Citation>Riancho J, Castanedo-V&#xe1;zquez D, Gil-Bea F, et al. ALS-derived fibroblasts exhibit reduced proliferation rate, cytoplasmic TDP-43 aggregation and a higher susceptibility to DNA damage. J Neurol. 2020 doi: 10.1007/s00415-020-09704-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-09704-8</ArticleId><ArticleId IdType="pubmed">31938860</ArticleId></ArticleIdList></Reference><Reference><Citation>Murata T, Ohtsuka C, Terayama Y. Increased mitochondrial oxidative damage and oxidative DNA damage contributes to the neurodegenerative process in sporadic amyotrophic lateral sclerosis. Free Radic Res. 2008;42:221&#x2013;225. doi: 10.1080/10715760701877262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10715760701877262</ArticleId><ArticleId IdType="pubmed">18344116</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsumoto H, Santella RM, Liu X, et al. Oxidative stress biomarkers in sporadic ALS. Amyotroph Lateral Scler. 2008;9:177&#x2013;183. doi: 10.1080/17482960801933942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960801933942</ArticleId><ArticleId IdType="pmc">PMC4332387</ArticleId><ArticleId IdType="pubmed">18574762</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H, Garcon G, Patin F, et al. Panel of oxidative stress and inflammatory biomarkers in ALS: a pilot study. Can J Neurol Sci. 2017;44:90&#x2013;95. doi: 10.1017/cjn.2016.284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/cjn.2016.284</ArticleId><ArticleId IdType="pubmed">27774920</ArticleId></ArticleIdList></Reference><Reference><Citation>Spencer PS, Nunn PB, Hugon J, et al. Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. Science. 1987;237:517&#x2013;522. doi: 10.1126/SCIENCE.3603037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/SCIENCE.3603037</ArticleId><ArticleId IdType="pubmed">3603037</ArticleId></ArticleIdList></Reference><Reference><Citation>Spencer PS, Palmer VS, Ludolph AC. On the decline and etiology of high-incidence motor system disease in West Papua (southwest New Guinea) Mov Disord. 2005;20:S119&#x2013;S126. doi: 10.1002/mds.20552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.20552</ArticleId><ArticleId IdType="pubmed">16092101</ArticleId></ArticleIdList></Reference><Reference><Citation>Khabazian I, Bains JS, Williams DE, et al. Isolation of various forms of sterol &#x3b2;-d-glucoside from the seed of Cycas circinalis: neurotoxicity and implications for ALS-parkinsonism dementia complex. J Neurochem. 2002;82:516&#x2013;528. doi: 10.1046/j.1471-4159.2002.00976.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2002.00976.x</ArticleId><ArticleId IdType="pubmed">12153476</ArticleId></ArticleIdList></Reference><Reference><Citation>Vega A, Bell EA. &#x3b1;-Amino-&#x3b2;-methylaminopropionic acid, a new amino acid from seeds of Cycas circinalis. Phytochemistry. 1967;6:759&#x2013;762. doi: 10.1016/S0031-9422(00)86018-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0031-9422(00)86018-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi A, Matsumoto H. Methylazoxymethanol, the aglycone of cycasin. Fed Proc. 1964;23:1354&#x2013;1356.</Citation><ArticleIdList><ArticleId IdType="pubmed">14236148</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto Y, Tanimura T. Effect of prenatal methylazoxymethanol acetate exposure on the motor behavior of the rat offspring. Congenit Anom (Kyoto) 1989;29:51&#x2013;58. doi: 10.1111/j.1741-4520.1989.tb00734.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1741-4520.1989.tb00734.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabata RC, Wilson JMB, Ly P, et al. Chronic exposure to dietary sterol glucosides is neurotoxic to motor neurons and induces an ALS&#x2013;PDC phenotype. NeuroMolecular Med. 2008;10:24&#x2013;39. doi: 10.1007/s12017-007-8020-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12017-007-8020-z</ArticleId><ArticleId IdType="pmc">PMC2814814</ArticleId><ArticleId IdType="pubmed">18196479</ArticleId></ArticleIdList></Reference><Reference><Citation>Esclaire F, Kisby G, Spencer P, et al. The Guam cycad toxin methylazoxymethanol damages neuronal DNA and modulates tau mRNA expression and excitotoxicity. Exp Neurol. 1999;155:11&#x2013;21. doi: 10.1006/EXNR.1998.6962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/EXNR.1998.6962</ArticleId><ArticleId IdType="pubmed">9918700</ArticleId></ArticleIdList></Reference><Reference><Citation>Kisby GE, Fry RC, Lasarev MR, et al. The cycad genotoxin MAM modulates brain cellular pathways involved in neurodegenerative disease and cancer in a DNA damage-linked manner. PLoS ONE. 2011;6:e20911. doi: 10.1371/journal.pone.0020911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0020911</ArticleId><ArticleId IdType="pmc">PMC3121718</ArticleId><ArticleId IdType="pubmed">21731631</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu AS, Gehringer MM, Braidy N, et al. Excitotoxic potential of the cyanotoxin &#x3b2;-methyl-amino-l-alanine (BMAA) in primary human neurons. Toxicon. 2012;60:1159&#x2013;1165. doi: 10.1016/J.TOXICON.2012.07.169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.TOXICON.2012.07.169</ArticleId><ArticleId IdType="pubmed">22885173</ArticleId></ArticleIdList></Reference><Reference><Citation>Geri&#x107; M, Gajski G, Domijan AM, et al. Genotoxic effects of neurotoxin &#xdf;-N-methylamino-l-alanine in human peripheral blood cells. Chemosphere. 2019;214:623&#x2013;632. doi: 10.1016/j.chemosphere.2018.09.155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chemosphere.2018.09.155</ArticleId><ArticleId IdType="pubmed">30290362</ArticleId></ArticleIdList></Reference><Reference><Citation>Borenstein AR, Mortimer JA, Schellenberg GD, et al. The ALS/PDC syndrome of Guam and the cycad hypothesis. Neurology. 2009;72:473&#x2013;476. doi: 10.1212/01.wnl.0000344257.59693.cf.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000344257.59693.cf</ArticleId><ArticleId IdType="pubmed">19188582</ArticleId></ArticleIdList></Reference><Reference><Citation>Vazquez-Villase&#xf1;or I, Garwood CJ, Heath PR, et al. Expression of p16 and p21 in the frontal association cortex of ALS/MND brains suggests neuronal cell cycle dysregulation and astrocyte senescence in early stages of the disease. Neuropathol Appl Neurobiol. 2019;46:171&#x2013;185. doi: 10.1111/nan.12559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12559</ArticleId><ArticleId IdType="pmc">PMC7217199</ArticleId><ArticleId IdType="pubmed">31077599</ArticleId></ArticleIdList></Reference><Reference><Citation>Parakh S, Atkin JD. Protein folding alterations in amyotrophic lateral sclerosis. Brain Res. 2016;1648:633&#x2013;649. doi: 10.1016/j.brainres.2016.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.04.010</ArticleId><ArticleId IdType="pubmed">27064076</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaffer L-N, Carter WG. Do post-translational modifications influence protein aggregation in neurodegenerative diseases: a systematic review. Brain Sci. 2020;232:1&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7226274</ArticleId><ArticleId IdType="pubmed">32290481</ArticleId></ArticleIdList></Reference><Reference><Citation>Par&#xe9; B, Lehmann M, Beaudin M, et al. Misfolded SOD1 pathology in sporadic amyotrophic lateral sclerosis. Sci Rep. 2018 doi: 10.1038/s41598-018-31773-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-31773-z</ArticleId><ArticleId IdType="pmc">PMC6155098</ArticleId><ArticleId IdType="pubmed">30242181</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotter EL, Chen HJ, Shaw CE. TDP-43 proteinopathy and ALS: insights into disease mechanisms and therapeutic targets. Neurotherapeutics. 2015;12:352&#x2013;363. doi: 10.1007/s13311-015-0338-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-015-0338-x</ArticleId><ArticleId IdType="pmc">PMC4404432</ArticleId><ArticleId IdType="pubmed">25652699</ArticleId></ArticleIdList></Reference><Reference><Citation>Blokhuis AM, Groen EJN, Koppers M, et al. Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol. 2013;125:777&#x2013;794. doi: 10.1007/s00401-013-1125-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1125-6</ArticleId><ArticleId IdType="pmc">PMC3661910</ArticleId><ArticleId IdType="pubmed">23673820</ArticleId></ArticleIdList></Reference><Reference><Citation>Osaka M, Ito D, Suzuki N. Disturbance of proteasomal and autophagic protein degradation pathways by amyotrophic lateral sclerosis-linked mutations in ubiquilin 2. Biochem Biophys Res Commun. 2016;472:324&#x2013;331. doi: 10.1016/j.bbrc.2016.02.107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.02.107</ArticleId><ArticleId IdType="pubmed">26944018</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E, Durham HD. Failure of protein quality control in amyotrophic lateral sclerosis. Biochim Biophys Acta Mol Basis Dis. 2006;1762:1038&#x2013;1050. doi: 10.1016/j.bbadis.2006.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2006.06.006</ArticleId><ArticleId IdType="pubmed">16876390</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurel C, Dangoumau A, Marouillat S, et al. Causative genes in amyotrophic lateral sclerosis and protein degradation pathways: a link to neurodegeneration. Mol Neurobiol. 2018;55:6480&#x2013;6499. doi: 10.1007/s12035-017-0856-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0856-0</ArticleId><ArticleId IdType="pubmed">29322304</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang IF, Guo BS, Liu YC, et al. Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43. Proc Natl Acad Sci USA. 2012;109:15024&#x2013;15029. doi: 10.1073/pnas.1206362109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1206362109</ArticleId><ArticleId IdType="pmc">PMC3443184</ArticleId><ArticleId IdType="pubmed">22932872</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng CW, Lin MJ, Shen CKJ. Rapamycin alleviates pathogenesis of a new Drosophila model of ALS-TDP. J Neurogenet. 2015;29:59&#x2013;68. doi: 10.3109/01677063.2015.1077832.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/01677063.2015.1077832</ArticleId><ArticleId IdType="pubmed">26219309</ArticleId></ArticleIdList></Reference><Reference><Citation>Perera ND, Sheean RK, Lau CL, et al. Rilmenidine promotes MTOR-independent autophagy in the mutant SOD1 mouse model of amyotrophic lateral sclerosis without slowing disease progression. Autophagy. 2018;14:534&#x2013;551. doi: 10.1080/15548627.2017.1385674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2017.1385674</ArticleId><ArticleId IdType="pmc">PMC5915012</ArticleId><ArticleId IdType="pubmed">28980850</ArticleId></ArticleIdList></Reference><Reference><Citation>Foster A, Rea S. The role of sequestosome 1/p62 protein in amyotrophic lateral sclerosis and frontotemporal dementia pathogenesis. Neural Regen Res. 2020;15:2186&#x2013;2194. doi: 10.4103/1673-5374.284977.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.284977</ArticleId><ArticleId IdType="pmc">PMC7749485</ArticleId><ArticleId IdType="pubmed">32594029</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma S, Attarwala IY, Xie X. SQSTM1/p62: A potential target for neurodegenerative disease. ACS Chem Neurosci. 2019;10:2094&#x2013;2114. doi: 10.1021/acschemneuro.8b00516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.8b00516</ArticleId><ArticleId IdType="pmc">PMC6712989</ArticleId><ArticleId IdType="pubmed">30657305</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramesh N, Pandey UB. Autophagy dysregulation in ALS: when protein aggregates get out of hand. Front Mol Neurosci. 2017;10:1&#x2013;18. doi: 10.3389/fnmol.2017.00263.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00263</ArticleId><ArticleId IdType="pmc">PMC5572252</ArticleId><ArticleId IdType="pubmed">28878620</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal J, Str&#xf6;m AL, Kilty R, et al. P62 accumulates and enhances aggregate formation in model systems of familial amyotrophic lateral sclerosis. J Biol Chem. 2007;282:11068&#x2013;11077. doi: 10.1074/jbc.M608787200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M608787200</ArticleId><ArticleId IdType="pubmed">17296612</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanji K, Zhang HX, Mori F, et al. P62/sequestosome 1 binds to TDP-43 in brains with frontotemporal lobar degeneration with TDP-43 inclusions. J Neurosci Res. 2012;90:2034&#x2013;2042. doi: 10.1002/jnr.23081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.23081</ArticleId><ArticleId IdType="pubmed">22674379</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubino E, Rainero I, Chi&#xf2; A, et al. SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Neurology. 2012;79:1556&#x2013;1562. doi: 10.1212/WNL.0b013e31826e25df.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31826e25df</ArticleId><ArticleId IdType="pmc">PMC3655323</ArticleId><ArticleId IdType="pubmed">22972638</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Zhang N, Zhang L, et al. Autophagy regulates chromatin ubiquitination in DNA damage response through elimination of SQSTM1/p62. Mol Cell. 2016;63:34&#x2013;48. doi: 10.1016/j.molcel.2016.05.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2016.05.027</ArticleId><ArticleId IdType="pubmed">27345151</ArticleId></ArticleIdList></Reference><Reference><Citation>Fradet-Turcotte A, Canny MD, Escribano-D&#xed;az C, et al. 53BP1 is a reader of the DNA-damage-induced H2A Lys 15 ubiquitin mark. Nature. 2013;499:50&#x2013;54. doi: 10.1038/nature12318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12318</ArticleId><ArticleId IdType="pmc">PMC3955401</ArticleId><ArticleId IdType="pubmed">23760478</ArticleId></ArticleIdList></Reference><Reference><Citation>Brady OA, Meng P, Zheng Y, et al. Regulation of TDP-43 aggregation by phosphorylation andp62/SQSTM1. J Neurochem. 2011;116:248&#x2013;259. doi: 10.1111/j.1471-4159.2010.07098.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2010.07098.x</ArticleId><ArticleId IdType="pubmed">21062285</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YP, Zheng ZZ, Chen XP, et al. SQSTM1 mutations in Han Chinese populations with sporadic amyotrophic lateral sclerosis. Neurobiol Aging. 2014;35:726.e7&#x2013;726.e9. doi: 10.1016/j.neurobiolaging.2013.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.09.008</ArticleId><ArticleId IdType="pubmed">24138988</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Curle AJ, Haider AM, Balmus G. The role of DNA damage response in amyotrophic lateral sclerosis. Essays Biochem. 2020;64:847&#x2013;861. doi: 10.1042/EBC20200002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/EBC20200002</ArticleId><ArticleId IdType="pmc">PMC7588667</ArticleId><ArticleId IdType="pubmed">33078197</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YJ, Chou TF, Pittman SK, et al. Keap1/Cullin3 modulates p62/SQSTM1 activity via UBA domain ubiquitination. Cell Rep. 2017;19:188&#x2013;202. doi: 10.1016/j.celrep.2017.08.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.08.019</ArticleId><ArticleId IdType="pmc">PMC5395095</ArticleId><ArticleId IdType="pubmed">28380357</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H, Kim MN, Ryu KY. Effect of p62/SQSTM1 polyubiquitination on its autophagic adaptor function and cellular survival under oxidative stress induced by arsenite. Biochem Biophys Res Commun. 2017;486:839&#x2013;844. doi: 10.1016/j.bbrc.2017.03.146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2017.03.146</ArticleId><ArticleId IdType="pubmed">28359760</ArticleId></ArticleIdList></Reference><Reference><Citation>Goode A, Rea S, Sultana M, et al. ALS-FTLD associated mutations of SQSTM1 impact on Keap1-Nrf2 signalling. Mol Cell Neurosci. 2016;76:52&#x2013;58. doi: 10.1016/j.mcn.2016.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2016.08.004</ArticleId><ArticleId IdType="pmc">PMC5062946</ArticleId><ArticleId IdType="pubmed">27554286</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartolome F, Esteras N, Martin-Requero A, et al. Pathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substrates. Sci Rep. 2017;7:1&#x2013;14. doi: 10.1038/s41598-017-01678-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-01678-4</ArticleId><ArticleId IdType="pmc">PMC5431917</ArticleId><ArticleId IdType="pubmed">28490746</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeo BK, Yu SW. Valosin-containing protein (VCP): structure, functions, and implications in neurodegenerative diseases. Animal Cells Syst (Seoul) 2016;20:303&#x2013;309. doi: 10.1080/19768354.2016.1259181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19768354.2016.1259181</ArticleId></ArticleIdList></Reference><Reference><Citation>Acs K, Luijsterburg MS, Ackermann L, et al. The AAA-ATPase VCP/p97 promotes 53BP1 recruitment by removing L3MBTL1 from DNA double-strand breaks. Nat Struct Mol Biol. 2011;18:1345&#x2013;1350. doi: 10.1038/nsmb.2188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2188</ArticleId><ArticleId IdType="pubmed">22120668</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayaki T, Ito H, Fukushima H, et al. Immunoreactivity of valosin-containing protein in sporadic amyotrophic lateral sclerosis and in a case of its novel mutant. Acta Neuropathol Commun. 2014;2:1&#x2013;14. doi: 10.1186/s40478-014-0172-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-014-0172-0</ArticleId><ArticleId IdType="pmc">PMC4297454</ArticleId><ArticleId IdType="pubmed">25492614</ArticleId></ArticleIdList></Reference><Reference><Citation>Koppers M, van Blitterswijk MM, Vlam L, et al. VCP mutations in familial and sporadic amyotrophic lateral sclerosis. Neurobiol Aging. 2012;33:837.e7&#x2013;837.e13. doi: 10.1016/j.neurobiolaging.2011.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.10.006</ArticleId><ArticleId IdType="pubmed">22078486</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitcho MA, Strider J, Carter D, et al. VCP mutations causing frontotemporal lobar degeneration disrupt localization of TDP-43 and induce cell death. J Biol Chem. 2009;284:12384&#x2013;12398. doi: 10.1074/jbc.M900992200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M900992200</ArticleId><ArticleId IdType="pmc">PMC2673306</ArticleId><ArticleId IdType="pubmed">19237541</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuetz AK, Kay LE. A dynamic molecular basis for malfunction in disease mutants of p97/VCP. Elife. 2016;5:1&#x2013;25. doi: 10.7554/eLife.20143.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.20143</ArticleId><ArticleId IdType="pmc">PMC5102582</ArticleId><ArticleId IdType="pubmed">27828775</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Boom J, Wolf M, Weimann L, et al. VCP/p97 extracts sterically trapped Ku70/80 rings from DNA in double-strand break repair. Mol Cell. 2016;64:189&#x2013;198. doi: 10.1016/j.molcel.2016.08.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2016.08.037</ArticleId><ArticleId IdType="pmc">PMC5161236</ArticleId><ArticleId IdType="pubmed">27716483</ArticleId></ArticleIdList></Reference><Reference><Citation>Montgomery DL. Astrocytes: form, functions, and roles in disease. Vet Pathol. 1994;31:145&#x2013;167. doi: 10.1177/030098589403100201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/030098589403100201</ArticleId><ArticleId IdType="pubmed">8203078</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow SA, Barres BA. Reactive astrocytes: production, function, and therapeutic potential. Immunity. 2017;46:957&#x2013;967. doi: 10.1016/J.IMMUNI.2017.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.IMMUNI.2017.06.006</ArticleId><ArticleId IdType="pubmed">28636962</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiffer D, Cordera S, Cavalla P, Migheli A. Reactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis. J Neurol Sci. 1996;139:27&#x2013;33. doi: 10.1016/0022-510X(96)00073-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(96)00073-1</ArticleId><ArticleId IdType="pubmed">8899654</ArticleId></ArticleIdList></Reference><Reference><Citation>Murayama S, Inoue K, Kawakami H, et al. A unique pattern of astrocytosis in the primary motor area in amyotrophic lateral sclerosis. Acta Neuropathol. 1991;82:456&#x2013;461. doi: 10.1007/BF00293379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00293379</ArticleId><ArticleId IdType="pubmed">1785258</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K, Chun SJ, Boillee S, et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci. 2008;11:251&#x2013;253. doi: 10.1038/nn2047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn2047</ArticleId><ArticleId IdType="pmc">PMC3137510</ArticleId><ArticleId IdType="pubmed">18246065</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai M, Re DB, Nagata T, et al. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci. 2007;10:615&#x2013;622. doi: 10.1038/nn1876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1876</ArticleId><ArticleId IdType="pmc">PMC3799799</ArticleId><ArticleId IdType="pubmed">17435755</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Giorgio FP, Boulting GL, Bobrowicz S, Eggan KC. Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. Cell Stem Cell. 2008;3:637&#x2013;648. doi: 10.1016/J.STEM.2008.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.STEM.2008.09.017</ArticleId><ArticleId IdType="pubmed">19041780</ArticleId></ArticleIdList></Reference><Reference><Citation>Re DB, Le Verche V, Yu C, et al. Necroptosis drives motor neuron death in models of both sporadic and familial ALS. Neuron. 2014;81:1001&#x2013;1008. doi: 10.1016/J.NEURON.2014.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.NEURON.2014.01.011</ArticleId><ArticleId IdType="pmc">PMC3951532</ArticleId><ArticleId IdType="pubmed">24508385</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchetto MCN, Muotri AR, Mu Y, et al. Non-cell-autonomous effect of human SOD1G37R astrocytes on motor neurons derived from human embryonic stem cells. Cell Stem Cell. 2008;3:649&#x2013;657. doi: 10.1016/J.STEM.2008.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.STEM.2008.10.001</ArticleId><ArticleId IdType="pubmed">19041781</ArticleId></ArticleIdList></Reference><Reference><Citation>Kia A, McAvoy K, Krishnamurthy K, et al. Astrocytes expressing ALS-linked mutant FUS induce motor neuron death through release of tumor necrosis factor-alpha. Glia. 2018;66:1016&#x2013;1033. doi: 10.1002/glia.23298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23298</ArticleId><ArticleId IdType="pmc">PMC5873384</ArticleId><ArticleId IdType="pubmed">29380416</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer K, Ferraiuolo L, Miranda CJ, et al. Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS. Proc Natl Acad Sci USA. 2014;111:829&#x2013;832. doi: 10.1073/pnas.1314085111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1314085111</ArticleId><ArticleId IdType="pmc">PMC3896192</ArticleId><ArticleId IdType="pubmed">24379375</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovi&#x10d;i&#x107; A, Gitler AD. Distinct repertoires of microRNAs present in mouse astrocytes compared to astrocyte-secreted exosomes. PLoS ONE. 2017;12:e0171418. doi: 10.1371/journal.pone.0171418.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0171418</ArticleId><ArticleId IdType="pmc">PMC5289606</ArticleId><ArticleId IdType="pubmed">28152040</ArticleId></ArticleIdList></Reference><Reference><Citation>Varcianna A, Myszczynska MA, Castelli LM, et al. Micro-RNAs secreted through astrocyte-derived extracellular vesicles cause neuronal network degeneration in C9orf72 ALS. EBioMedicine. 2019;40:626&#x2013;635. doi: 10.1016/J.EBIOM.2018.11.067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.EBIOM.2018.11.067</ArticleId><ArticleId IdType="pmc">PMC6413467</ArticleId><ArticleId IdType="pubmed">30711519</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso M, Pozzi S, Tortarolo M, et al. Mutant copper-zinc superoxide dismutase (SOD1) induces protein secretion pathway alterations and exosome release in astrocytes: Implications for disease spreading and motor neuron pathology in amyotrophic lateral sclerosis. J Biol Chem. 2013;288:15699&#x2013;15711. doi: 10.1074/jbc.M112.425066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.425066</ArticleId><ArticleId IdType="pmc">PMC3668729</ArticleId><ArticleId IdType="pubmed">23592792</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad LI, Yerbury JJ, Turner BJ, et al. Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms. Proc Natl Acad Sci USA. 2014;111:3620&#x2013;3625. doi: 10.1073/pnas.1312245111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1312245111</ArticleId><ArticleId IdType="pmc">PMC3948312</ArticleId><ArticleId IdType="pubmed">24550511</ArticleId></ArticleIdList></Reference><Reference><Citation>Iguchi Y, Eid L, Parent M, et al. Exosome secretion is a key pathway for clearance of pathological TDP-43. Brain. 2016;139:3187&#x2013;3201. doi: 10.1093/brain/aww237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww237</ArticleId><ArticleId IdType="pmc">PMC5840881</ArticleId><ArticleId IdType="pubmed">27679482</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathi P, Rodriguez-Muela N, Klim JR, et al. Reactive astrocytes promote ALS-like degeneration and intracellular protein aggregation in human motor neurons by disrupting autophagy through TGF-&#x3b2;1. Stem Cell Rep. 2017;9:667&#x2013;680. doi: 10.1016/J.STEMCR.2017.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.STEMCR.2017.06.008</ArticleId><ArticleId IdType="pmc">PMC5549875</ArticleId><ArticleId IdType="pubmed">28712846</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao C, Devlin A, Chouhan AK, et al. Mutant C9orf72 human iPSC-derived astrocytes cause non-cell autonomous motor neuron pathophysiology. Glia. 2020;68:1046&#x2013;1064. doi: 10.1002/glia.23761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23761</ArticleId><ArticleId IdType="pmc">PMC7078830</ArticleId><ArticleId IdType="pubmed">31841614</ArticleId></ArticleIdList></Reference><Reference><Citation>Wouters MD, van Gent DC, Hoeijmakers JHJ, Pothof J. MicroRNAs, the DNA damage response and cancer. Mutat Res Fundam Mol Mech Mutagen. 2011;717:54&#x2013;66. doi: 10.1016/j.mrfmmm.2011.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mrfmmm.2011.03.012</ArticleId><ArticleId IdType="pubmed">21477600</ArticleId></ArticleIdList></Reference><Reference><Citation>Tominaga K, Srikantan S, Lee EK, et al. Competitive regulation of nucleolin expression by HuR and miR-494. Mol Cell Biol. 2011;31:4219&#x2013;4231. doi: 10.1128/mcb.05955-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mcb.05955-11</ArticleId><ArticleId IdType="pmc">PMC3187287</ArticleId><ArticleId IdType="pubmed">21859890</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi J, Fujimoto H, Sato J, et al. Nucleolin participates in DNA double-strand break-induced damage response through MDC1-dependent pathway. PLoS ONE. 2012;7:e49245. doi: 10.1371/journal.pone.0049245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0049245</ArticleId><ArticleId IdType="pmc">PMC3492271</ArticleId><ArticleId IdType="pubmed">23145133</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamura K, Qi F, Meng Q, et al. Nucleolar protein nucleolin functions in replication stress-induced DNA damage responses. J Radiat Res. 2019;60:281&#x2013;288. doi: 10.1093/jrr/rry114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jrr/rry114</ArticleId><ArticleId IdType="pmc">PMC6530621</ArticleId><ArticleId IdType="pubmed">30839063</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon I, Xiang S, Kato M, et al. Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells. Science. 2014;345:1139&#x2013;1145. doi: 10.1126/science.1254917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1254917</ArticleId><ArticleId IdType="pmc">PMC4459787</ArticleId><ArticleId IdType="pubmed">25081482</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KH, Zhang P, Kim HJ, et al. C9orf72 dipeptide repeats impair the assembly, dynamics, and function of membrane-less organelles. Cell. 2016;167:774&#x2013;788. doi: 10.1016/j.cell.2016.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.10.002</ArticleId><ArticleId IdType="pmc">PMC5079111</ArticleId><ArticleId IdType="pubmed">27768896</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider L, Fumagalli M, Di Fagagna FDA. Terminally differentiated astrocytes lack DNA damage response signaling and are radioresistant but retain DNA repair proficiency. Cell Death Differ. 2012;19:582&#x2013;591. doi: 10.1038/cdd.2011.129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2011.129</ArticleId><ArticleId IdType="pmc">PMC3307974</ArticleId><ArticleId IdType="pubmed">21979466</ArticleId></ArticleIdList></Reference><Reference><Citation>Bylicky MA, Mueller GP, Day RM. Radiation resistance of normal human astrocytes: the role of non-homologous end joining DNA repair activity. J Radiat Res. 2019;60:37&#x2013;50. doi: 10.1093/jrr/rry084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jrr/rry084</ArticleId><ArticleId IdType="pmc">PMC6373697</ArticleId><ArticleId IdType="pubmed">30423138</ArticleId></ArticleIdList></Reference><Reference><Citation>Swain U, Subba Rao K. Study of DNA damage via the comet assay and base excision repair activities in rat brain neurons and astrocytes during aging. Mech Ageing Dev. 2011;132:374&#x2013;381. doi: 10.1016/j.mad.2011.04.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mad.2011.04.012</ArticleId><ArticleId IdType="pubmed">21600238</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto A, Nakamura Y, Kobayashi N, et al. Neurons and astrocytes exhibit lower activities of global genome nucleotide excision repair than do fibroblasts. DNA Repair (Amst) 2007;6:649&#x2013;657. doi: 10.1016/j.dnarep.2006.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dnarep.2006.12.006</ArticleId><ArticleId IdType="pubmed">17236820</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollensworth SB, Shen CC, Sim JE, et al. Glial cell type-specific responses to menadione-induced oxidative stress. Free Radic Biol Med. 2000;28:1161&#x2013;1174. doi: 10.1016/S0891-5849(00)00214-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0891-5849(00)00214-8</ArticleId><ArticleId IdType="pubmed">10889445</ArticleId></ArticleIdList></Reference><Reference><Citation>LeDoux SP, Williams BA, Hollensworth BS, et al. Glial cell-specific differences in repair of O6-methylguanine. Cancer Res. 1996;56:5615&#x2013;5619.</Citation><ArticleIdList><ArticleId IdType="pubmed">8971165</ArticleId></ArticleIdList></Reference><Reference><Citation>Harlan BA, Pehar M, Killoy KM, Vargas MR. Enhanced SIRT6 activity abrogates the neurotoxic phenotype of astrocytes expressing ALS-linked mutant SOD1. FASEB J. 2019;33:7084&#x2013;7091. doi: 10.1096/fj.201802752R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201802752R</ArticleId><ArticleId IdType="pmc">PMC6529338</ArticleId><ArticleId IdType="pubmed">30841754</ArticleId></ArticleIdList></Reference><Reference><Citation>Duval K, Grover H, Han LH, et al. Modeling physiological events in 2D vs. 3D cell culture. Physiology. 2017;32:266&#x2013;277. doi: 10.1152/physiol.00036.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physiol.00036.2016</ArticleId><ArticleId IdType="pmc">PMC5545611</ArticleId><ArticleId IdType="pubmed">28615311</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu W, Hill SE, Nathan WJ, et al. Neuronal enhancers are hotspots for DNA single-strand break repair. Nature. 2021 doi: 10.1038/s41586-021-03468-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03468-5</ArticleId><ArticleId IdType="pubmed">33767446</ArticleId></ArticleIdList></Reference><Reference><Citation>Pehar M, Harlan BA, Killoy KM, Vargas MR. Role and therapeutic potential of astrocytes in amyotrophic lateral sclerosis. Curr Pharm Des. 2018;23:5010&#x2013;5021. doi: 10.2174/1381612823666170622095802.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612823666170622095802</ArticleId><ArticleId IdType="pmc">PMC5740017</ArticleId><ArticleId IdType="pubmed">28641533</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>